CTAGE9

Across TCGA pan-cancer cohorts, CTAGE9 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CTAGE9 data layer compared with 3 for mutation status.

The strongest signal is observed in small cell lung cancer (SCLC), where higher CTAGE9 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CTAGE9 expression acts as an unfavorable survival marker, although some lineages such as SCLC and KIRP show a favorable association.

SCLC, ACC, and CHOL are the cancer types where CTAGE9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Median	II,III,IV	1.000	0.462	.005	44	view →
ACC	DFS	Median	III,IV	0.234	0.579	.009	37	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	24	view →
UCEC	DFS	Tertile	II,III,IV	0.343	0.652	.012	16	view →
COAD	OS	Median	All	0.484	0.789	.012	15	view →
KIRP	OS	Tertile	III,IV	0.814	0.183	.003	14	view →
UCS	OS	Quartile	All	0.630	0.325	.024	10	view →
THCA	DFS	Median	II,III,IV	0.879	0.960	.006	10	view →
MESO	OS	Tertile	IV	0.928	0.324	.003	9	view →
GBM	DFS	Tertile	All	0.152	0.258	.045	9	view →
UVM	DFS	Tertile	III,IV	0.186	0.707	.027	9	view →
BLCA	OS	Median	III,IV	0.568	0.342	.016	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CTAGE9–SCLC (OS)

Open the SCLC breakdown →